Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
The aim was to better understand the clinical characteristics of patients with mucormycosis in western China. We retrospectively investigated the clinical, laboratory, radiological and treatment profiles of mucormycosis patients during a 10-year period (2010–2019). As a result, 59 proven mucormycosi...
Saved in:
Main Authors: | Junyan Qu, Xijiao Liu, Xiaoju Lv |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a047d29131a94e8d90d6258debe8b85f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
by: F. Yuan, et al.
Published: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
by: Nagehan Didem Sarı, et al.
Published: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
by: Vivek Pai, et al.
Published: (2021) -
First reported case of late recurrence of pulmonary mucormycosis in a renal transplant recipient with poorly controlled diabetes mellitus
by: Cheuk Cheung Derek Leung, et al.
Published: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
by: Tonya N. Watkins, et al.
Published: (2018)